Iran headlines, oil slips, central banks hedge
Iran stayed the macro driver. Crude drifted lower on “maybe peace” chatter, taking a little near-term inflation pressure off the tape. Helpful, not a reset. Flows still felt headline-led, and risk budgets didn’t come roaring back.
In Europe, the ECB held rates and put uncertainty front and center, explicitly linking the conflict to energy and inflation. Even with oil easing, policymakers are treating energy as the swing factor. That keeps the tone cautious and positioning twitchy around the next headline.
AI: bid, but selective
Tech kept doing what it’s been doing: pay up for cleaner AI compute exposure and punish anything that needs perfect execution and perfect multiples.
- Applied Materials (AMAT) up on resilient performance tied to AI chip demand. When the tape gets jumpy, money hides in the picks-and-shovels of the buildout.
- Alphabet (GOOGL) up on AI and cloud growth. Investors are underwriting AI as an earnings mix shift now, not just a story.
“Good” still wasn’t always good enough:
- Netflix (NFLX) down despite strong results and expansion plans. This reads like valuation and positioning: high expectations, fewer marginal buyers, and capital still crowding into direct AI infrastructure leverage.
- In the AI-compute corner, CoreWeave underperformed Nebius Group one year post-IPO. Theme exposure isn’t a free pass; structure and execution decide who gets paid.
- Meta bumped top exec comp via stock options. Not a one-day catalyst, but it fits the AI talent war: companies are paying to keep builders in-house.
Health care: deals, binaries, steady operators
Health care was cleaner: one strategic buy, one biotech stumble, one operator getting rewarded for execution.
- Merck (MRK) announced a $6.7B acquisition of Terns Pharmaceuticals. Big pharma is still shopping for pipeline. Part confidence, part necessity—patent clocks don’t stop and internal timelines don’t magically compress.
- Anavex (AVXL) down after withdrawing its European marketing application for an Alzheimer’s therapy. Single-asset biotech stays binary; the regulatory path shifts and the stock turns into a coin flip again.
- Cardinal Health (CAH) up on pharma strength and margins. Boring works when macro is noisy and investors want earnings mechanics they can model.
Corporate actions and consumer signals
Corporate activity stayed busy. Windows are open, but pricing is tight and anything balance-sheet related gets interrogated.
- Sturm, Ruger (RGR) up after Beretta initiated a tender offer to lift its stake by 20%. A tender creates a technical bid and signals serious intent.
- Liberty Energy announced a proposed $450M convertible senior notes offering. Converts can lower cash interest, but they bring dilution math and an overhang—especially with oil sliding.
- SSR Mining confirmed the sale of the Çöpler mine in a $1.5B deal. Real portfolio surgery. Cabral Gold launched a C$20M bought deal—smaller resource names still live on equity oxygen.
- Legal & General and Manulife WAM formed a global asset management alliance. Scale and distribution without the full M&A headache.
Consumer and housing leaned softer:
- KB Home (KBH) down after cutting full-year sales guidance, pointing to weaker homebuyer demand amid war uncertainty. Big-ticket confidence remains fragile.
- Chewy beat on Q4 revenue and put out a 2027 revenue outlook above consensus—one of the few longer-dated demand positives on the page.
- Dollar General named Jerry Fleeman Jr CEO. No fireworks, but it’s the usual “operational reset” chapter for a pressured retailer.
- Nutanix (NTNX) down despite share gains. Progress is fine; the market wants monetization and margin trajectory, not just adoption.
What mattered
- Oil eased on peace chatter, but the tape stayed headline-driven.
- The ECB held and kept energy/inflation uncertainty in focus.
- AI strength persisted (AMAT, GOOGL), while crowded “good news” names still got sold (NFLX, NTNX).
- Health care delivered the contrast: MRK buying pipeline, AVXL reminding everyone biotech is binary, CAH doing steady work.
The day’s message was simple: macro is a headline machine, so investors kept paying for durability and punishing anything that needed perfect conditions.